Delivery Order SPE2DB24D2205-SPE2DB25FEEDL
Award Date
6/26/25
Potential Completion Date
7/18/25
Potential Value
$34K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to AmerisourceBergen Drug Corporation's Corporate Office division. The $32,448.80 firm-fixed-price delivery order is for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with an ultimate completion date of June 24, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML. The contract is a delivery order with a firm fixed price of $48,673.20 and an ultimate completion date of August 29, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $34,342.56 and a completion date of June 20, 2025. The contract is a firm-fixed-price delivery order, indicating the government is acquiring a specific quantity of a commercial product at an established price....
Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a $31,755.04 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide TAKHZYRO 300 MG/2 ML syringes. Performance will take place in Conshohocken, Pennsylvania over a period spanning from June 28, 2023 through July 20, 2023. The Defense Logistics Agency Troop Support Medical, which supports the medical supply needs of the U.S. Department...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of TREMFYA 100 MG/ML ONE-PRESSML, a medical product, with a ceiling value of $15,405.74 and a performance period ending on June 12, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $13,125.47, is for the supply of TREMFYA 100 MG/ML ONE-PRESSML, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2025 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price of $26,918.72 and a performance period through May 2025. The award is not set aside and covers the supply of the pharmaceutical product SKYRIZI 150 MG/ML PENML. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $16,792.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the medication TREMFYA 100 MG/ML INJECTORML, with an ultimate completion date of May 9, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $15,507.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication TREMFYA 100 MG/ML INJECTORML, with a performance period extending to April 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award, valued at $50,592.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...